Identifying novel regulatory pathways underlying T helper 1 cell immune responses
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
批准号:
10001826
负责人:
Kenneth Joseph Oestreich
金额:
$22.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-23 至 2023-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
During the course of an immune response, CD4+ T helper cells identify invading pathogens, proliferate, and
secrete cytokines to aid in immune-mediated clearance of infection. This results in an initial expansion of
effector CD4+ T cells at the peak of infection. These include effector T helper 1 (TH1) cells, which mediate
immune responses to intracellular pathogens. As pathogen is eliminated, the effector cell population is
reduced, with the exception of a subset of long-lived memory T cells capable of responding more quickly and
robustly to a repeated encounter with the pathogen. This effector-to-memory transition is required for the
generation of both naturally occurring long-term and vaccine-induced immunity.
In addition to their contribution to the memory cell pool, an emerging body of literature suggests that TH1
cells may also engage in aspects of humoral immunity via plasticity shared with the T follicular helper (TFH) cell
subset. TFH cells engage in cognate interactions with B cells to assist in the production of pathogen-neutralizing
antibodies. Taken together, the above findings suggest that TH1 cells are capable of undergoing stage-specific
phenotypic changes that allow for contributions to humoral and memory cell immunity. Currently, however,
gaps in knowledge exist regarding the molecular mechanisms by which these critical cellular transitions occur.
Bcl-6 is a transcriptional repressor required for both TFH and central memory T (TCM) cell differentiation.
Recently, we demonstrated that TH1 cells up-regulate Bcl-6-dependent TFH- and TCM-like profiles in response to
diminished antigen stimulation and IL-2 signaling. Intriguingly, these cells also co-express IL-6Rα and IL-7R,
cytokine receptors that support TFH and TCM differentiation, respectively (“IL-6Rα+IL-7R+ cells”). Importantly, our
preliminary data indicate that subsequent exposure to IL-6 or IL-7 differentially regulates TFH and TCM genes in
IL-6Rα+IL-7R+ cells. Therefore, we hypothesize that IL-6- and IL-7-dependent alterations to the transcriptional
landscape of TH1-derived IL-6Rα+IL-7R+ cells allow them to contribute to humoral and memory cell responses.
To test this hypothesis we will 1) determine the IL-6-dependent effects on phenotype and function of IL-6Rα+IL-
7R+ cells, 2) assess the IL-7-dependent effects on phenotype and function of IL-6Rα+IL-7R+ cells, and
3) assess the functional contribution of IL-6Rα+IL-7R+ cells to immune responses in vivo.
The findings obtained from these studies will be significant, as they will provide novel insight into the
molecular mechanisms that support previously unappreciated roles for TH1 cells in humoral and memory
responses. In doing so, our work will provide the molecular building blocks for the design of novel
immunotherapeutic strategies and increasingly effective vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
-
批准号:10377575
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2018
-
负责人:Kenneth Joseph Oestreich
-
依托单位:
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
-
批准号:9914202
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2018
-
负责人:Kenneth Joseph Oestreich
-
依托单位:
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
-
批准号:10132970
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2018
-
负责人:Kenneth Joseph Oestreich
-
依托单位:
Regulation of T helper cell differentiation by integrated STAT and Ikaros zinc finger transcription factor mechanisms
-
批准号:9527895
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2017
-
负责人:Kenneth Joseph Oestreich
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: